CORETOX 100
MD
$1.00
This item has been added to your cart.
Should I order it along with the items in my shopping cart?
Check location
Check location
| ● Product Name | Coretox 100U |
| ● Active Ingredients | Clostridium botulinum toxin type A (Hall strain) - Core Neurotoxin without animal-derived components |
| ● Efficacy | Wrinkle improvement |
| ● Packing unit (Volume) | Store at -15~-5℃ or at 2~ 8℃ in a refrigerator, in hermetic container |
| ● Detail information | 1. Benign essential blepharospasm in adults aged 18 or more |
| 2. To improve moderate to severe glabellar wrinkles related to eyebrow wrinkle muscle (corrugator muscle) | |
| 3. temporarily and/or procerus muscle activity in adults aged from 20 to 65 | |
| 4. Muscle spasticity: upper limb local muscle spasticity related to stroke in adults aged 20 or more | |
| 5. Treatment of moderate to severe lateral canthal lines associated with orbicularis oculi activity in adult patients 20~65 years of age | |
| 6. Treatment of cervical dystonia in adult patients, to reduce the severity of abnormal head position and neck pain | |
| ● Description | A lyophilized white powder for injection with a colorless transparent vial. colorless transparent solution when dissolved when dissolved with saline |
| ● Product Name | Coretox 100U |
| ● Active Ingredients | Clostridium botulinum toxin type A (Hall strain) - Core Neurotoxin without animal-derived components |
| ● Efficacy | Wrinkle improvement |
| ● Packing unit (Volume) | Store at -15~-5℃ or at 2~ 8℃ in a refrigerator, in hermetic container |
| ● Detail information | 1. Benign essential blepharospasm in adults aged 18 or more |
| 2. To improve moderate to severe glabellar wrinkles related to eyebrow wrinkle muscle (corrugator muscle) | |
| 3. temporarily and/or procerus muscle activity in adults aged from 20 to 65 | |
| 4. Muscle spasticity: upper limb local muscle spasticity related to stroke in adults aged 20 or more | |
| 5. Treatment of moderate to severe lateral canthal lines associated with orbicularis oculi activity in adult patients 20~65 years of age | |
| 6. Treatment of cervical dystonia in adult patients, to reduce the severity of abnormal head position and neck pain | |
| ● Description | A lyophilized white powder for injection with a colorless transparent vial. colorless transparent solution when dissolved when dissolved with saline |
연관상품
